One Platform for Managing ALL Incidental Findings

If your EMR is capturing incidental findings and diagnoses that are lost to follow-up, wouldn’t you like to know? Illuminate Discovery360 combines our people, process, and Workflow Conscious AI to prevent patients with incidentalomas from being “lost to follow-up” and save more lives with existing clinical resources.

Ensure Timely
Follow-up

Enable unstructured clinical data to drive timely patient care

Improve Patient
Follow-up Care

Follow up with patients to elevate care and improve outcome.

Uncover New Revenue Streams

Rapid ROI from incremental imaging, testing, and surgical procedures.

Close the Loop on
Patient Follow-Up Tracking

Illuminate Discovery360’s Workflow Conscious AI technology combs through your EMR data to identify, track, and treat disease. Here’s how it works:

Our Nurse Navigator service can manage and run all aspects of your surveillance program, enabling coveted clinical staff to focus on direct patient follow-up care.

Our navigator team will follow your departmental policies when setting up clinical workflows and protocols, including analytics to help measure the success of your follow-up surveillance program.

Applicable to Many Diseases

Discovery360 incorporates the people, process, and technology to identify lost patients with a range of disease entities. We currently offer solutions for discovering and managing the following diseases. If you’re interested in applying Discovery360 to a disease, but don’t see it on this list yet, reach out and let us know.

1

AAA

Patients whose aneurysms are repaired prior to rupture have at least a 90% survival rate. The survival rate drops to 20% at rupture. 

Request a DemoLearn More

AAA

2

TAA

Complications of aortic aneurysmal disease (thoracic and abdominal) are a leading cause of death in the United States. Most go undetected.

Request a DemoLearn More

TAA

0

Lung

Lung cancer is the leading cause of cancer related death worldwide, and only 16% of lung cancers in the US are detected at early stages.

Request a DemoLearn More

Lung

4

Adrenal

Incidental adrenal masses are common, estimated to occur in approximately 3% to 7% of adults.

Request a DemoLearn More

Adrenal

5

Pancreas

2.2% of upper abdominal CT exams and 19.6% of MRI exams report a pancreatic cystic lesion which may be malignant and need follow up or intervention.

Request a DemoLearn More

Pancreas

6

IVC Filter

The FDA reported 921 IVC filter complications between 2005 and 2010, including ebolizations at the filter site, IVC penetration, IVC obstruction, and more.

Request a DemoLearn More

IVC Filter

7

Cerebral

Every 18 minutes, a brain aneurysm ruptures in the U.S.; 


50% of these are fatal.

Request a DemoLearn More

Cerebral

Discovery360 incorporates the following Illuminate solutions. Together they streamline clinical staff workflows by making vital clinical information and operational insights available on-demand and at the point of care.

Close the loop on patient follow-up tracking.

Learn More

Relevant patient information
at the point of read.

Learn More

Meaningful data to improve your practice.

Learn More
Discovery360 reviewed our entire PACS allowing us to identify and contact at-risk patients who had no idea they needed additional care.

Steven Okuhn, MD
Vascular Surgeon Kaiser Permanente
San Francisco Medical Center
REGISTER